Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Fairhurst

Showing results (81-90 of 95) with videos related to

Pageof 10
Sort By:
ACS Infectious Diseases|September 8, 2025
Identification of α-Azacyclic Acetamide-Based Inhibitors of <i>P. falciparum</i> Na<sup>+</sup> Pump (<i>Pf</i>ATP4) with Fast-Killing Asexual Blood-Stage Antimalarial Activity by Phenotypic ScreeningArturo Casas, Leah S Imlay, Vandana Thathy, et al.
European Journal of Medicinal Chemistry|March 30, 2024
Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 proteinWilliam Nguyen, Coralie Boulet, Madeline G Dans, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2006
N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptakeJ R Boot, S L Boulet, B P Clark, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Mapping the genomic landscape of multidrug resistance in <i>Plasmodium falciparum</i> and its impact on parasite fitnessSachel Mok, Tomas Yeo, Davin Hong, et al.
Science Advances|November 8, 2023
Mapping the genomic landscape of multidrug resistance in <i>Plasmodium falciparum</i> and its impact on parasite fitnessSachel Mok, Tomas Yeo, Davin Hong, et al.
Cell Chemical Biology|March 24, 2023
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasomeIoanna Deni, Barbara H Stokes, Kurt E Ward, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Identification of the drug/metabolite transporter 1 as a marker of quinine resistance in a NF54×Cam3.II <i>P. falciparum</i> genetic crossMariko Kanai, Sachel Mok, Tomas Yeo, et al.
Nature Microbiology|July 6, 2026
Identification of genetic markers of quinine partial resistance in Plasmodium falciparumMariko Kanai, Sachel Mok, Tomas Yeo, et al.
Cell Chemical Biology|July 31, 2024
Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malariaAloysus Lawong, Suraksha Gahalawat, Sneha Ray, et al.
Nature Communications|September 30, 2022
A G358S mutation in the Plasmodium falciparum Na<sup>+</sup> pump PfATP4 confers clinically-relevant resistance to cipargaminDeyun Qiu, Jinxin V Pei, James E O Rosling, et al.
Pageof 10

Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
ACS Infectious Diseases|September 8, 2025
Identification of α-Azacyclic Acetamide-Based Inhibitors of <i>P. falciparum</i> Na<sup>+</sup> Pump (<i>Pf</i>ATP4) with Fast-Killing Asexual Blood-Stage Antimalarial Activity by Phenotypic ScreeningArturo Casas, Leah S Imlay, Vandana Thathy, et al.
European Journal of Medicinal Chemistry|March 30, 2024
Activity refinement of aryl amino acetamides that target the P. falciparum STAR-related lipid transfer 1 proteinWilliam Nguyen, Coralie Boulet, Madeline G Dans, et al.
Bioorganic & Medicinal Chemistry Letters|February 25, 2006
N-Alkyl-N-arylmethylpiperidin-4-amines: novel dual inhibitors of serotonin and norepinephrine reuptakeJ R Boot, S L Boulet, B P Clark, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Mapping the genomic landscape of multidrug resistance in <i>Plasmodium falciparum</i> and its impact on parasite fitnessSachel Mok, Tomas Yeo, Davin Hong, et al.
Science Advances|November 8, 2023
Mapping the genomic landscape of multidrug resistance in <i>Plasmodium falciparum</i> and its impact on parasite fitnessSachel Mok, Tomas Yeo, Davin Hong, et al.
Cell Chemical Biology|March 24, 2023
Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasomeIoanna Deni, Barbara H Stokes, Kurt E Ward, et al.
Biorxiv : the Preprint Server for Biology|October 10, 2024
Identification of the drug/metabolite transporter 1 as a marker of quinine resistance in a NF54×Cam3.II <i>P. falciparum</i> genetic crossMariko Kanai, Sachel Mok, Tomas Yeo, et al.
Nature Microbiology|July 6, 2026
Identification of genetic markers of quinine partial resistance in Plasmodium falciparumMariko Kanai, Sachel Mok, Tomas Yeo, et al.
Cell Chemical Biology|July 31, 2024
Identification of potent and reversible piperidine carboxamides that are species-selective orally active proteasome inhibitors to treat malariaAloysus Lawong, Suraksha Gahalawat, Sneha Ray, et al.
Nature Communications|September 30, 2022
A G358S mutation in the Plasmodium falciparum Na<sup>+</sup> pump PfATP4 confers clinically-relevant resistance to cipargaminDeyun Qiu, Jinxin V Pei, James E O Rosling, et al.
Pageof 10